Fig. 1: Determinants for clinical worsening and overall survival. | Nature Cancer

Fig. 1: Determinants for clinical worsening and overall survival.

From: Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohort

Fig. 1

af, Kaplan–Meier plots (n = 178 patients) of clinical worsening-free survival (left) and overall survival (right), stratified according to ECOG score at the last onco-hematological consultation (n = 177) (a), type of cancer (n = 178) (b), onco-hematological status (n = 178) (c), administration of cytotoxic chemotherapy inhibitors in the past 3 months (n = 178) (d), administration of targeted therapy inhibitors in the past 3 months (n = 178) (e) and administration of immune checkpoint inhibitors in the past 3 months (n = 178) (f). Pointwise 95% confidence limits are reported (shaded intervals). Plus symbols indicate censored observations. Statistical significance was determined by Wald test of the univariable Cox models.

Back to article page